AHF Applauds Novel Gonorrhea Treatment streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
A new Phase III trial has found that zoliflodacin can effectively treat the bacterial infection that has become resistant to nearly every available drug.
AHF • AHF Applauds Novel Gonorrhea Treatment aidshealth.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from aidshealth.org Daily Mail and Mail on Sunday newspapers.
Received GSK royalties of $57.0 million and net product revenues of $13.7 million in the third quarter of 2023Launched first-in-class therapy XACDURO® for treatment of hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia caused by susceptible strains of AcinetobacterAnnounced positive.
A Phase 3 study of oral zoliflodacin met the primary endpoint when compared against the combination of injectable ceftriaxone and oral azithromycin, a current international standard of care.Positive top-line study results are a significant milestone in the development of a first-in-class antibiotic against drug-resi.